Dark Streaming/Mobile Old Site Home Daily Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:27:46 EDT Fri 24 Mar 2023
Enter Symbol
or Name
USA
CA



News for U:BXRX from 2022-03-25 to 2023-03-24 - 20 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2023-02-23 08:00U:BXRXNews ReleaseBaudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
2023-01-24 08:00U:BXRXNews ReleaseBaudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
2022-12-08 08:00U:BXRXNews ReleaseBaudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
2022-12-06 16:11U:BXRXNews ReleaseBaudax Bio Announces Closing of $5 Million Public Offering
2022-12-02 14:47U:BXRXNews ReleaseBaudax Bio Announces Pricing of $5 Million Public Offering
2022-11-30 16:50U:BXRXNews ReleaseBaudax Bio Announces 1-for-40 Reverse Stock Split
2022-11-08 16:09U:BXRXNews ReleaseBaudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights
2022-09-19 16:05U:BXRXNews ReleaseBaudax Bio Announces Distribution of Series B Preferred Stock to Holders of its Common Stock
2022-09-08 16:05U:BXRXNews ReleaseBaudax Bio to Present at the 24th Annual H.C. Wainwright Healthcare Conference
2022-09-01 14:57U:BXRXNews ReleaseBaudax Bio Announces Closing of $6.2 Million Public Offering
2022-08-29 22:04U:BXRXNews ReleaseBaudax Bio Announces Pricing of $6.2 Million Public Offering
2022-08-22 08:00U:BXRXNews ReleaseBaudax Bio receives notice of allowance for U.S. Patent Application covering use of ANJESO(TM) for the treatment of moderate to severe pain
2022-08-11 07:00U:BXRXNews ReleaseBaudax Bio Reports Second Quarter 2022 Financial Results and Business Highlights
2022-06-01 08:00U:BXRXNews ReleaseBaudax Bio Announces Dosing of First Cohort in First-in-Man, Phase I Clinical Study Evaluating BX2000
2022-05-18 08:00U:BXRXNews ReleaseBaudax Bio to Present at the H.C. Wainwright Annual Global Life Sciences Conference
2022-05-17 19:00U:BXRXNews ReleaseBaudax Bio Announces $2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2022-05-05 17:00U:BXRXNews ReleaseBaudax Bio Announces Date of Reconvened Annual Meeting of Shareholders
2022-05-04 17:00U:BXRXNews ReleaseBaudax Bio Reports First Quarter 2022 Financial Results and Business Highlights
2022-05-02 16:05U:BXRXNews ReleaseBaudax Bio to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 5, 2022
2022-04-13 08:00U:BXRXNews ReleaseBaudax Bio to Present at NobleCon18 Investor Conference